探索性代谢分析用于在雌激素剥夺下描述尿膀的代谢概况
Wei Zhang1, Qingbo Yang1, Yingying Song1
1Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Frontiers in endocrinology
|June 17, 2024
概括
缺少雌激素会破坏膀功能,改变其代谢特征. 这项研究确定了关键的生物标志物,并突出了氨基酸代谢失衡,为与更年期相关的膀功能障碍提供了见解.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 内分泌学 在内分泌学.
- 代谢学 代谢学 代谢学
背景情况:
- 雌激素平衡对于正常的膀功能至关重要.
- 在更年期常见的雌激素缺乏会导致膀功能障碍.
- 将雌激素损失与膀功能障碍联系在一起的确切机制尚不清楚.
研究的目的:
- 为了研究由于雌激素缺乏而导致的膀组织的代谢变化.
- 为了确定与雌激素缺乏引起的膀功能障碍相关的潜在生物标志物.
- 阐明雌激素水平与膀代谢途径之间的关系.
主要方法:
- 建立了一个卵巢切除小鼠模型来模拟雌激素剥夺.
- 进行皮下雌激素注射以补充.
- 使用非向方法分析了膀组织代谢量.
- 使用生物信息学进行数据分析和生物标志物识别.
主要成果:
- 在老鼠中成功模拟了雌激素缺乏.
- 鉴定出了3,5-四甲基二甲尼丁,lysoPC (15:0) 和皮质醇作为潜在的生物标志物.
- 发现雌激素缺乏主要导致膀内的氨基酸代谢失衡.
结论:
- 这项研究提供了第一个在雌激素剥夺下膀的全面代谢地图.
- 这些发现为了解更年期相关的膀疾病提供了重要的实验基础.
- 已识别的生物标志物和代谢变化可以指导未来的治疗策略.
相关概念视频
Drug Elimination by Renal Route: Tubular Secretion
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Renal Drug Excretion: Tubular Reabsorption
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
Renal Drug Excretion: Tubular Secretion
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
One-Compartment Open Model: Urinary Excretion Data and Determination of k
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also be...
Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
Urine Studies I: Urinalysis
Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...


